VAREX IMAGING CORPORATION financials

  1. Home
  2. Financials
  3. VREX
VREX CIK 0001681622

Source: EDGAR filings · Built 2026-06-02T04:20:18Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow 18.20M 19.90M 87.40M -4.60M 77.30M -10.60M
EBITDA -600.00K 63.20M 110.30M 121.80M 111.40M 5.80M
Working Capital 454.60M 454.00M 495.50M 436.80M 387.60M 361.40M
Net Debt 256.90M 308.00M 317.20M 347.30M 315.30M 384.50M
Gross Margin 34.40% 31.68% 32.49% 32.99% 33.19% 25.76%
Operating Margin -3.29% 3.96% 8.63% 10.26% 9.06% -4.56%
Net Margin -8.32% -6.02% 5.31% 3.53% 2.13% -7.84%
Return on Equity (ROE) -14.88% -9.22% 8.35% 5.68% 3.60% -12.82%
Return on Assets (ROA) -6.35% -4.02% 3.79% 2.56% 1.52% -5.08%
Current Ratio 3.43× 3.32× 4.04× 3.52× 3.33× 3.25×
Debt-to-Equity 0.85× 0.90× 0.83× 0.82× 0.95× 1.07×
Effective Tax Rate -18.07% 1066.00% -53.04% 30.79% 37.41% 20.94%
Cash Conversion Ratio -0.59× -0.97× 2.29× 0.56× 5.32× -0.23×
Accruals Ratio -0.10× -0.08× -0.05× 0.01× -0.07× -0.06×
SBC % of Revenue 1.78% 1.89% 1.51% 1.63% 1.70% 1.81%
CapEx Coverage 1.77× 1.73× 5.16× 0.79× 6.05× 0.55×
Free Cash Flow Per Share $0.44 $0.49 $1.74 $-0.11 $1.92 $-0.27

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
P/E Trailing (Diluted) — — 17.56× 28.96× 66.47× —
P/FCF 27.16× 24.44× 10.81× — 14.90× —
FCF Yield 3.68% 4.09% 9.25% — 6.71% —
EV / EBITDA — 12.62× 9.78× 9.81× 12.95× 149.60×
P/S 0.59× 0.60× 0.85× 0.99× 1.38× 0.65×
P/B 1.05× 0.93× 1.34× 1.59× 2.33× 1.07×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue from Contract with Customer, Excluding Assessed Tax 844.60M 811.00M 893.40M 859.40M 818.10M —
Revenues — 811.00M 893.40M 859.40M 818.10M 738.30M
Cost of Goods and Services Sold 554.10M 554.10M 603.10M 575.90M 546.60M —
Cost of Revenue — — — 575.90M 546.60M 548.10M
Gross Profit 290.50M 256.90M 290.30M 283.50M 271.50M 190.20M
Research and Development Expense 91.10M 87.00M 84.80M 77.00M 71.90M 78.90M
Selling, General and Administrative Expense 133.30M 137.80M 128.40M 118.30M 125.50M 142.20M
Operating Expenses 318.30M 224.80M 213.20M 195.30M 197.40M 223.90M
Operating Income (Loss) -27.80M 32.10M 77.10M 88.20M 74.10M -33.70M
Income Tax Expense (Benefit) 10.70M 53.30M -16.60M 13.70M 10.70M -15.20M
Net Income (Loss) Attributable to Parent -70.30M -48.80M 47.40M 30.30M 17.40M -57.90M
Earnings Per Share, Basic $-1.70 $-1.20 $1.18 $0.76 $0.44 $-1.49
Weighted Average Number of Shares Outstanding, Basic 41.40M 40.80M 40.30M 39.80M 39.30M 38.80M
Earnings Per Share, Diluted $-1.70 $-1.20 $1.07 $0.73 $0.43 $-1.49
Weighted Average Number of Shares Outstanding, Diluted 41.40M 40.80M 50.30M 41.60M 40.30M 38.80M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 145.00M 168.70M 152.60M 89.40M 144.60M 100.60M
Assets, Current 641.80M 649.90M 658.30M 609.90M 554.20M 522.00M
Assets 1.11B 1.21B 1.25B 1.18B 1.15B 1.14B
Long-term Debt 367.50M 443.40M 442.60M 414.40M 434.50M 455.30M
Liabilities, Current 187.20M 195.90M 162.80M 173.10M 166.60M 160.60M
Long-term Debt, Excluding Current Maturities 366.00M 397.10M 441.10M 412.30M 431.70M 452.80M
Liabilities 620.80M 670.40M 668.60M 637.70M 651.00M 673.70M
Stockholders' Equity Attributable to Parent 472.60M 529.10M 567.70M 533.40M 483.30M 451.70M
Common Stock, Shares, Outstanding 41.69M 41.09M 40.53M 40.09M 39.44M 39.06M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities 41.70M 47.30M 108.40M 16.90M 92.60M 13.20M
Payments to Acquire Property, Plant, and Equipment 22.90M 26.90M 20.70M 21.30M 15.10M 23.50M
Net Cash Provided by (Used in) Investing Activities 10.30M -27.50M -44.90M -48.40M -16.20M -26.90M
Net Cash Provided by (Used in) Financing Activities -75.90M -3.30M -200.00K -23.80M -32.30M 83.60M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (VREX CIK 0001681622), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

HAL

HALLIBURTON COMPANY

RARE

ULTRAGENYX PHARMACEUTICAL INC.

ARVN

ARVINAS, INC.